HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.
Julissa Soto, Speaker at Immunity Conferences
Oral Presentation (In-person)
Julissa Soto, Julissa Soto Latino Health Equity Consulting, United States

Description of Presentation: Cultural Validation is a critical tool for bridging gaps between public health agencies and the communities they serve. At the onset of the COVID-19 Pandemic, policymakers and public health officials often cited “vaccine hesitancy” as a ke [....] » Read More

Prasoon Sheoran, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Prasoon Sheoran, Directorate of Health and Family Welfare, India

Background: Case based surveillance is effective in preventing and controlling the incidence of infectious disease. VPD surveillance was first launched in Haryana state of India in 2014. We evaluated the system to identify its strengths and gaps. Methods: A descriptive cross s [....] » Read More

Ismail Hossain, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Ismail Hossain, Globe Biotech, Bangladesh

Antibiotic resistance is now a days one of the biggest challenges headed by the health professionals globally, it is causing more quickly due to the misuse and overuse of antibiotics. Bacteria are becoming resistant to commonly used antibiotics and various factors have been ident [....] » Read More

Samson Gebremedhin Gebreselassie, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Samson Gebremedhin Gebreselassie, Project HOPE, Ethiopia

Background: Uninterrupted availability of potent vaccines requires robust vaccine supply chain and logistics system (VSCLS). With special focus on remote and underserved settings, we assessed the reach and bottlenecks to end-to-end delivery of the Ethiopian VSCLS after the initia [....] » Read More

Fisseha Shiferie Tadesse, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Fisseha Shiferie Tadesse, Project HOPE, Ethiopia

Background: Ethiopia is the fourth leading contributor to the global total of zero-dose children (those who lack the first dose of the pentavalent vaccine) and has substantial regional variations in zero-dose children. This study explored the spatial pattern of zero-dose children [....] » Read More

Gashaw Andargie Biks, Speaker at Vaccines Conferences
Oral Presentation (In-person)
Gashaw Andargie Biks, Project HOPE, Ethiopia

Background: The WHO/UNICEF estimates that over 18 million children in low- and middle-income countries, especially in Africa and South-East Asia, are not being vaccinated, with Ethiopia being one of the top four countries contributing to this issue. Objective: To estimate [....] » Read More

Juste Christin Bie Ondo, Speaker at Vaccine Conferences
Oral Presentation (In-person)
Juste Christin Bie Ondo, Centre de recherche Médicale de Lambaréné(CERMEL), Gabon

Background: Vaccine efficacy is often an overarching estimate that may overlook specific variations linked to epidemiological factors, genetic backgrounds, and socioeconomic conditions. Some studies have reported lower vaccine efficacy in single vaccines among sub-Saharan African [....] » Read More

Sean Yanik, Speaker at Vaccine Conferences
Poster Presentation (In-person)
Sean Yanik, Johns Hopkins, United States

In 2021, there were 247 million clinical cases and 619,000 deaths from malaria. RTS, S, the first and only WHO approved vaccine for malaria, targets the pre-erythrocytic stage antigen circumsporozoite protein (CSP) and provides only limited efficacy, reducing clinical malaria by [....] » Read More

Sean Yanik, Speaker at Vaccine Conferences
Poster Presentation (In-person)
Sean Yanik, Johns Hopkins, United States

In 2022, there were an estimated 249 million clinical cases and 608,000 deaths from malaria. A vaccine against Plasmodium falciparum would provide a critical tool for malaria control and eventual eradication. RTS,S, the first WHO approved vaccine for malaria, targets the antigen [....] » Read More

Yen Hung Chow, Speaker at Vaccines Conferences
Poster Presentation (In-person)
Yen Hung Chow, National Health Research Institutes, Taiwan

Enterovirus A71 (EV-A71) and coxsackievirus A (CVA) were the primary causative agents of hand, foot, and mouth disease (HFMD), the heightened occurrence of HFMD outbreaks associated with CVA10 worldwide has questioned this perspective. Due to the absence of an effective vaccine o [....] » Read More

Subodh Adhikari, Speaker at Vaccines Conferences
Poster Presentation (In-person)
Subodh Adhikari, Maharajgung Medical Campus, Nepal

Introduction: Vaccination against Coronavirus Disease 2019 (COVID-19) is essential for controlling the ongoing cases of this disease. Citrobacter infections of the bones and joints are extremely uncommon. Thromboembolism and deep vein thrombosis are very rare complications. Ca [....] » Read More

Nzolameso Makaya Jennifer, Speaker at Immunology Conferences
Poster Presentation (In-person)
Nzolameso Makaya Jennifer, Hopital General De Reference De Kimbanseke Pierre Pokom, Congo

70% of people over 65 are hypertensive; high blood pressure increases the risk of exposure to cardiovascular disease (myocardial infarction and heart failure) and stroke. This is a public health problem, given the aging of the population. There are few studies carried out in eld [....] » Read More

Yusuf Abdulsalam Olawale, Speaker at Vaccines Conferences
Poster Presentation (In-person)
Yusuf Abdulsalam Olawale, Medical Research Council Unit, Gambia

Background: Pneumococcal pneumonia remains a leading cause of under-5 mortality, causing over 340,000 deaths in 2016. Carriage of pneumococcus is a prerequisite for invasive disease.  Notwithstanding the drastic reductions in the incidence of vaccine-type (VT) invasive [....] » Read More

Akumu Esther Joy, Speaker at Vaccines Conferences
Poster Presentation (In-person)
Akumu Esther Joy, Infectious Diseases Institute, Uganda

Background: Coronavirus disease (COVID-19) was declared a pandemic by the World Health Organization (WHO) on 11th March 2020. COVID-19 vaccination is one of the strategies that was employed to contain COVID-19 infection. In Uganda, COVID-19 vaccination campaigns began in Mar [....] » Read More

Carly Contri, Speaker at Vaccines Conferences
Oral Presentation (Virtual)
Carly Contri, American Academy of Pediatrics, United States

Abstract: Vaccine hesitancy has increased as pediatric immunization rates have decreased, with lowest rates for children experiencing social determinants of health. To address these issues, 24 immunization partnership grants were awarded to practices and organizations across the [....] » Read More

Vincenzo Alfano, Speaker at Vaccines Conferences
Oral Presentation (Virtual)
Vincenzo Alfano, University of Napoli Parthenope, Italy

Attitudes toward vaccination are doubtless an important determinant of public health, and this became evident after the first year of the last COVID-19 pandemic. The issue, long-debated within European societies, especially with respect to occasional surges of diseases in given y [....] » Read More

Souhir Ayadi, Speaker at Immunology Conferences
Poster Presentation (In-person)
Souhir Ayadi, Faculty of Medicine, Tunisia

Introduction: The COVID-19 vaccination campaign started in 2021 was a crucial step in significantly reducing mortality, especially among elderly people at high risk of serious forms. However, its impact on the progression of the disease has not been a frequent subject of research [....] » Read More

Souhir Ayadi, Speaker at Immunology Conferences
Poster Presentation (In-person)
Souhir Ayadi, Faculty of Medicine, Tunisia

Introduction:  Klebsiella pneumoniae is a gram-negative bacterium that has become a well-recognized cause of nosocomial infections. Hospital outbreaks due to multiresistant K.pneumoniae strains have been described throughout the world. We aimed to describe the occurrenc [....] » Read More

Scientific Programs coming soon..

Watsapp